Insider · CIK 0001886388
Anne Elizabeth Borgman
Files at CRIS (CURIS INC), STRO (SUTRO BIOPHARMA, INC.), NXTC (NextCure, Inc.). First filing -, latest -.
In brief
Anne Elizabeth Borgman files SEC Form 4 as director and officer at CRIS (CURIS INC), and also at STRO (SUTRO BIOPHARMA, INC.), NXTC (NextCure, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anne Elizabeth Borgman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +6,800 | $5.29 | $36k | 6,800 | Jul 9, 2026 |
| Jun 18, 2026 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,340 | $0.00 | $0 | 2,340 | Jun 22, 2026 |
| Jun 20, 2025 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,700 | $0.00 | $0 | 18,700 | Jun 24, 2025 |
| May 20, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +14,400 | $3.13 | $45k | 14,400 | May 22, 2025 |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Common Stock | +53,125 | $0.00 | $0 | 106,223 | May 5, 2025 |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Common Stock | +15,938 | $0.00 | $0 | 122,161 | May 5, 2025 |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | FTax withholding Common Stock | -24,709 | $1.07 | $26k | 97,452 | May 5, 2025 |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Restricted Stock Unit (RSU)derivative | -53,125 | $0.00 | $0 | 21,875 | May 5, 2025 |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Restricted Stock Unit (RSU)derivative | -15,938 | $0.00 | $0 | 17,812 | May 5, 2025 |
| Feb 28, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Common Stock | +37,500 | $0.00 | $0 | 61,874 | Mar 4, 2025 |
| Feb 28, 2025 | STRO SUTRO BIOPHARMA, INC. | FTax withholding Common Stock | -15,405 | $1.59 | $24k | 46,469 | Mar 4, 2025 |
| Mar 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Common Stock | +11,250 | $0.00 | $0 | 57,719 | Mar 4, 2025 |
| Mar 1, 2025 | STRO SUTRO BIOPHARMA, INC. | FTax withholding Common Stock | -4,621 | $1.59 | $7,347 | 53,098 | Mar 4, 2025 |
| Feb 28, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Restricted Stock Unit (RSU)derivative | -37,500 | $0.00 | $0 | 75,000 | Mar 4, 2025 |
| Mar 1, 2025 | STRO SUTRO BIOPHARMA, INC. | MOption exercise Restricted Stock Unit (RSU)derivative | -11,250 | $0.00 | $0 | 33,750 | Mar 4, 2025 |
| Jan 28, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +1,600 | $3.13 | $5,008 | 1,600 | Jan 30, 2025 |
Questions about Anne Elizabeth Borgman
Answered from the filings on this page, as of the latest one.
Is Anne Elizabeth Borgman buying or selling?
Anne Elizabeth Borgman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anne Elizabeth Borgman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anne Elizabeth Borgman has 0.
Where does Anne Elizabeth Borgman file Form 4?
Anne Elizabeth Borgman has filed Form 4 at CRIS (CURIS INC); STRO (SUTRO BIOPHARMA, INC.) as CHIEF MEDICAL OFFICER; NXTC (NextCure, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.